Se connecter Inscription gratuite

Theratechnologies Marge opérationnelle

Quel est le Marge opérationnelle de Theratechnologies?

Le Marge opérationnelle de Theratechnologies, Inc. est 6.93%

Quelle est la définition de Marge opérationnelle?



La marge opérationnelle est le ratio du résultat opérationnel divisé par les ventes nettes et présenté en pourcentage.

Operating margin is an indicator of profitability and is often used to compare the profitability of companies and industries of differing sizes. Companies are collections of projects and markets, individual areas can be judged on how successful they are at adding to the corporate net profit. Not all projects are of equal size, however, and one way to adjust for size is to divide the profit by sales revenue. The resulting ratio is the percentage of sales revenue that gets 'returned' to the company as net profits after all the related costs of the activity are deducted.

Marge opérationnelle des entreprises dans Health Care secteur sur TSX par rapport à Theratechnologies

Que fait Theratechnologies?

Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH-1902 for the treatment of triple negative breast cancer; and TH-1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.

Entreprises avec marge opérationnelle similaire à Theratechnologies